In addition, combinations of the endogenous retrovirus HERV-H and herpes virus antigens resulted in highly increased cellular immune responses among both the MS patients and healthy subjects (Brudek et al. 2004). The gene discussed is FUT1; the disease is myeloid sarcoma.